Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Zomedica Corp (AMEX: ZOM) closed at $0.15 down -2.24% from its previous closing price of $0.16. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 2.18 million shares were traded. ZOM stock price reached its highest trading level at $0.16 during the session, while it also had its lowest trading level at $0.1525.
Ratios:
For a deeper understanding of Zomedica Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.87 and its Current Ratio is at 11.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 12 ’24 when Klass Russell Kevin bought 299,993 shares for $0.16 per share. The transaction valued at 46,529 led to the insider holds 2,000,050 shares of the business.
Klass Russell Kevin bought 500,000 shares of ZOM for $75,100 on Jun 11 ’24. The Vice President of Sales now owns 1,700,057 shares after completing the transaction at $0.15 per share. On Jun 10 ’24, another insider, Klass Russell Kevin, who serves as the Vice President of Sales of the company, bought 200,007 shares for $0.15 each. As a result, the insider paid 29,941 and bolstered with 1,200,057 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 155879216 and an Enterprise Value of 69180312. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.76 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at 2.664 whereas that against EBITDA is -2.507.
Stock Price History:
Over the past 52 weeks, ZOM has reached a high of $0.23, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -1.90%, while the 200-Day Moving Average is calculated to be -1.47%.
Shares Statistics:
For the past three months, ZOM has traded an average of 5.19M shares per day and 2476030 over the past ten days. A total of 979.95M shares are outstanding, with a floating share count of 962.81M. Insiders hold about 1.75% of the company’s shares, while institutions hold 8.59% stake in the company. Shares short for ZOM as of 1719532800 were 61524931 with a Short Ratio of 11.86, compared to 1717113600 on 59166006. Therefore, it implies a Short% of Shares Outstanding of 61524931 and a Short% of Float of 6.39.
